1-3 of 3
Christopher Pericone
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 2 Study of Daratumumab (DARA) Plus Bortezomib, Cyclophosphamide, and Dexamethasone (D-VCd) in a Diverse Patient Population with Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis: Aquarius

Michael Rosenzweig, Yvonne Efebera, Efstathios Kastritis, Brandon Blue, Faizi Jamal, Monique C Minnema, Christopher Pericone, Sandra Vasey, Yuping Chen, Sonja Kotoulek, Bart Vandael, Joana Duran, Samer Khaled, NamPhuong Tran, Jessica Vermeulen, Vaishali Sanchorawala
Journal: Blood
Blood (2023) 142 (Supplement 1): 4785.
https://doi.org/10.1182/blood-2023-181953
Published: 2023
Journal Articles

Phase 2 Study of Daratumumab (DARA) Plus Bortezomib, Cyclophosphamide, and Dexamethasone (D-VCd) in Patients with Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis: Aquarius

Vaishali Sanchorawala, Michael Rosenzweig, Christopher Pericone, Sandra Y. Vasey, Xiang Qin, Sonja Marie Kotoulek, Bart Vandael, Joana Duran, Samer Khaled, NamPhuong Tran, Efstathios Kastritis
Journal: Blood
Blood (2022) 140 (Supplement 1): 10163–10164.
https://doi.org/10.1182/blood-2022-163615
Published: 2022
Journal Articles

Use of Anti-Infective Prophylaxis in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma Patients Initiating Treatment with Daratumumab

Ming-Hui Tai, PhD, Eric M. Ammann, PhD, Shuchita Kaila, PhD, Christopher Pericone, Ajaybir Singh, Thomas S. Lin, MD PhD, Faith E. Davies
Journal: Blood
Blood (2020) 136 (Supplement 1): 23–24.
https://doi.org/10.1182/blood-2020-134086
Published: 2020